According To The World Health Organization, New Global Covid-19 Cases And Deaths Seem To Be Stable, Although At A “High Level”

According to the WHO, new worldwide coronavirus cases and fatalities have seemed to have reached a plateau after rising steadily for almost two months.

According To The World Health Organization, New Global Covid-19 Cases And Deaths Seem To Be Stable, Although At A “High Level”

The World Health Organization’s Director-General, TedrosAdhanomGhebreyesus, said at a news conference on Wednesday that the worldwide number of COVID-19 cases and fatalities had stabilized last week after rising for almost two months. According to him, with more than 4.5 million cases and 68,000 fatalities annually, the situation is steady at a very high level.

According To The World Health Organization, New Global Covid-19 Cases And Deaths Seem To Be Stable, Although At A "High Level"

The scenario differs from one area to another as well. According to the World Health Organization, the Americas saw an 8 percent rise in new cases last week, while the Western Pacific experienced a 20 percent increase. According to the World Health Organization, Europe and the Americas saw increases in new fatalities of 11 percent and 10 percent, respectively. According to Tedros, as long as this virus is spreading everywhere, it poses a danger to everyone and everything.

With nearly 1 million new cases recorded last week, the United States had the most significant number of new cases of any nation. According to statistics from the Centers for Disease Control and Prevention, little more than 51 percent of the country has received all of its vaccinations. During the press conference, Tedros and other WHO members reiterated their recommendation against booster injections of the COVID-19 vaccine, despite the fact that low-income countries are struggling to get enough doses to protect their most vulnerable. 

The United States, on the other hand, seems set to proceed with its plan to begin giving booster injections this autumn, pending clearance from various government authorities. Johnson & Johnson released intermediate study results on Wednesday, stating that the evidence justifies administering a second dosage of the vaccine.